Page last updated: 2024-11-05

tranexamic acid and Liver Cirrhosis

tranexamic acid has been researched along with Liver Cirrhosis in 10 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"To report a case of toxic epidermal necrolysis (TEN) induced by orally administered tranexamic acid in a patient with liver cirrhosis and acute rectal bleeding."3.79Tranexamic acid-induced toxic epidermal necrolysis. ( Aguado Gil, L; Idoate Gastearena, MA; Marques Martin, L; Pretel Irazabal, M, 2013)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's6 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Louro, J1
Andersen, K1
Dudaryk, R1
Heidet, M1
Amathieu, R1
Audureau, E1
Augusto, O1
Nicolazo de Barmon, V1
Rialland, A1
Schmitz, D1
Pierrang, F1
Marty, J1
Chollet-Xémard, C1
Thirion, O1
Jacob, L1
Dibiasi, C1
Wiegele, M1
Gratz, J1
Pretel Irazabal, M1
Marques Martin, L1
Aguado Gil, L1
Idoate Gastearena, MA1
Joshi, N1
Kopec, AK1
Towery, K1
Williams, KJ1
Luyendyk, JP1
Perdigão, JP1
de Almeida, PC1
Rocha, TD1
Mota, MR1
Soares, EC1
Alves, AP1
Sousa, FB1
Ickx, BE1
van der Linden, PJ1
Melot, C1
Wijns, W1
de Pauw, L1
Vandestadt, J1
Hut, F1
Pradier, O1
McCormick, PA1
Ooi, H1
Crosbie, O1
Burak, KW1
Lee, SS1
Beck, PL1
Maeda, T1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Efficacy and Safety of Early Administration of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding: a Multicenter, Randomized, Double Blind, Placebo-controlled Trial (Modified by amendment1)[NCT03023189]Phase 4500 participants (Anticipated)Interventional2017-04-03Recruiting
Use of Metformin in Prevention and Treatment of Cardiac Fibrosis in PAI-1 Deficient Population[NCT05317806]Phase 415 participants (Anticipated)Interventional2022-10-10Active, not recruiting
Efficacy of Local Hemostatic Management in Implant Surgery in Anticoagulated Patients on Warfarin: a Randomized Clinical Study[NCT04846114]71 participants (Actual)Interventional2016-03-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for tranexamic acid and Liver Cirrhosis

ArticleYear
Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.
    Gut, 2001, Volume: 49, Issue:6

    Topics: Adrenergic beta-Antagonists; Antifibrinolytic Agents; Diagnosis, Differential; Esophageal and Gastri

2001

Trials

3 trials available for tranexamic acid and Liver Cirrhosis

ArticleYear
Efficacy and tolerance of early administration of tranexamic acid in patients with cirrhosis presenting with acute upper gastrointestinal bleeding: a study protocol for a multicentre, randomised, double-blind, placebo-controlled trial (the EXARHOSE study)
    BMJ open, 2018, 08-10, Volume: 8, Issue:8

    Topics: Administration, Intravenous; Adult; Antifibrinolytic Agents; Double-Blind Method; France; Gastrointe

2018
Postoperative bleeding after dental extraction in liver pretransplant patients.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2012, Volume: 70, Issue:3

    Topics: Adult; Antifibrinolytic Agents; Cross-Sectional Studies; Dental Care for Chronically Ill; Female; He

2012
Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
    Transfusion, 2006, Volume: 46, Issue:4

    Topics: Adult; Aprotinin; Blood Loss, Surgical; Erythrocyte Transfusion; Female; Fibrinolysis; Hemostatics;

2006

Other Studies

6 other studies available for tranexamic acid and Liver Cirrhosis

ArticleYear
Correction of Severe Coagulopathy and Hyperfibrinolysis by Tranexamic Acid and Recombinant Factor VIIa in a Cirrhotic Patient After Trauma: A Case Report.
    A & A case reports, 2017, Sep-01, Volume: 9, Issue:5

    Topics: Aged; Antifibrinolytic Agents; Blood Coagulation; Factor VIIa; Humans; Liver Cirrhosis; Male; Recomb

2017
Orthotopic liver transplantation in a patient receiving apixaban for portal vein thrombosis.
    Journal of clinical anesthesia, 2019, Volume: 56

    Topics: Aged; Blood Loss, Surgical; Carcinoma, Hepatocellular; Dabigatran; Humans; Infusions, Intravenous; L

2019
Tranexamic acid-induced toxic epidermal necrolysis.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:3

    Topics: Aged; Antifibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Stevens-J

2013
The antifibrinolytic drug tranexamic acid reduces liver injury and fibrosis in a mouse model of chronic bile duct injury.
    The Journal of pharmacology and experimental therapeutics, 2014, Volume: 349, Issue:3

    Topics: 1-Naphthylisothiocyanate; Animals; Antifibrinolytic Agents; Bile Duct Diseases; Collagen Type I; Dis

2014
Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis.
    Gut, 1998, Volume: 42, Issue:5

    Topics: Aged; Antifibrinolytic Agents; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Stomach

1998
[A study on pathogenesis of gastric ulcer in patient with liver cirrhosis: with special reference to the gastric mucosal blood flow].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1988, Volume: 79, Issue:8

    Topics: Adult; Anti-Ulcer Agents; Gastric Mucosa; Humans; Liver Cirrhosis; Middle Aged; Regional Blood Flow;

1988